Jan 30, 2026 01:55PM

Oct 29, 2025 05:12AM

May 30, 2025 09:27AM

Sep 24, 2024 05:30AM

Jun 28, 2023 08:33AM

Mar 29, 2023 07:01AM

Mar 29, 2023 07:00AM Libtayo® (cemiplimab) in Combination with Chemotherapy Approved by European Commission for the First-line Treatment of Advanced PD-L1 Positive Non-small Cell Lung Cancer (NSCLC)

Mar 29, 2023 07:00AM

Nov 8, 2021 08:50AM

Oct 8, 2020 09:51AM

Jul 23, 2020 06:53AM

May 5, 2020 06:52AM

Feb 26, 2020 04:45AM

Aug 7, 2019 04:28AM Baird Upgrades Regeneron Pharma (REGN) to Outperform

Feb 7, 2019 06:29AM

Jan 3, 2019 07:06AM

Aug 3, 2018 05:42AM

Feb 9, 2018 04:42AM

Nov 3, 2017 02:58AM

Sep 11, 2017 11:33AM

Aug 1, 2017 05:21AM Baird Downgrades Regeneron Pharma (REGN) to Underperform

Mar 28, 2017 12:43PM

Mar 28, 2017 06:38AM

Jan 6, 2017 06:27AM

Dec 12, 2016 11:51AM

Nov 4, 2016 12:40PM

Sep 21, 2016 08:28AM

Aug 5, 2016 10:45AM Notable Analyst Rating Changes 8/5: (SYMC) (COH) (OAS) Upgraded; (ICPT) (PKI) (REGN) Downgraded

Aug 5, 2016 06:44AM

May 5, 2016 03:25PM

Apr 1, 2016 12:08PM

Apr 1, 2016 11:52AM

Feb 9, 2016 01:45PM

Aug 31, 2015 09:30AM

Jul 9, 2015 10:28AM Notable Analyst Rating Changes 7/9: (TRV) (MBLY) (JBHT) Upgraded; (SHAK) (REGN) (VR) Downgraded

Feb 20, 2015 10:46AM

Dec 24, 2014 07:51AM

Jan 15, 2013 02:23PM

Oct 16, 2012 03:38PM

Oct 4, 2012 12:54PM

Apr 25, 2012 11:05AM

Mar 29, 2012 03:24PM Baird Reiterates a 'Outperform' on Regeneron Pharma (REGN); Bullish Thesis Intact

Mar 27, 2012 08:26AM

Mar 21, 2012 12:14PM

Mar 21, 2012 10:49AM

Feb 13, 2012 04:12PM

Feb 7, 2012 07:32AM

Jan 10, 2012 10:51AM

Jan 10, 2012 09:16AM Regeneron (REGN) Surges On Strong Initial Eylea Uptake

Jan 10, 2012 07:16AM

28,060 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All